Lantheus Holdings, Inc. Depreciation
Lantheus Holdings, Inc. (LNTH) reported Depreciation of $800.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2017-02-23
- Lantheus Holdings, Inc. depreciation for the quarter ending 2016-12-31 was -$5.40M, a 345.45% decline year-over-year.
- Lantheus Holdings, Inc. depreciation for the quarter ending 2016-09-30 was $2.10M, a 10.53% increase year-over-year.
- Lantheus Holdings, Inc. depreciation for the quarter ending 2016-06-30 was $2.20M, a 10.00% increase year-over-year.
- Lantheus Holdings, Inc. depreciation for the quarter ending 2016-03-31 was $2.00M, a 64.91% decline year-over-year.
- Lantheus Holdings, Inc. depreciation for fiscal 2016 was $800.00K, a 93.22% decline from fiscal 2015.
- Lantheus Holdings, Inc. depreciation for fiscal 2015 was $11.80M, a 19.19% increase from fiscal 2014.
- Lantheus Holdings, Inc. depreciation for fiscal 2014 was $9.90M, a 6.45% increase from fiscal 2013.
- Lantheus Holdings, Inc. depreciation for fiscal 2013 was $9.30M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$3.30M derived: sum of 2 quarters · filed 2017-02-23 | -$1.10M derived: sum of 3 quarters · filed 2017-02-23 | $800.00K 10-K · filed 2017-02-23 |
| 2016-09-30 | $2.10M 10-Q · filed 2016-11-01 | $4.30M derived: sum of 2 quarters · filed 2016-11-01 | $6.20M 10-Q · filed 2016-11-01 | $8.50M derived: sum of 4 quarters · filed 2016-11-01 |
| 2016-06-30 | $2.20M 10-Q · filed 2016-08-04 | $4.10M 10-Q · filed 2016-08-04 | $6.40M derived: sum of 3 quarters · filed 2016-08-04 | $8.30M derived: sum of 4 quarters · filed 2016-11-01 |
| 2016-03-31 | $2.00M 10-Q · filed 2016-05-03 | $4.20M derived: sum of 2 quarters · filed 2016-05-03 | $6.10M derived: sum of 3 quarters · filed 2016-11-01 | $8.10M derived: sum of 4 quarters · filed 2016-11-01 |
| 2015-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | $4.10M derived: sum of 2 quarters · filed 2016-11-01 | $6.10M derived: sum of 3 quarters · filed 2016-11-01 | $11.80M 10-K · filed 2016-03-02 |
| 2015-09-30 | $1.90M 10-Q · filed 2016-11-01 | $3.90M derived: sum of 2 quarters · filed 2016-11-01 | $9.60M 10-Q · filed 2016-11-01 | $13.00M derived: sum of 4 quarters · filed 2016-11-01 |
| 2015-06-30 | $2.00M 10-Q · filed 2016-08-04 | $7.70M 10-Q · filed 2016-08-04 | $11.10M derived: sum of 3 quarters · filed 2016-08-04 | $13.30M derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | $5.70M 10-Q · filed 2016-05-03 | $9.10M derived: sum of 2 quarters · filed 2016-05-03 | $11.30M derived: sum of 3 quarters · filed 2016-05-03 | $13.40M derived: sum of 4 quarters · filed 2016-05-03 |
| 2014-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | $5.60M derived: sum of 2 quarters · filed 2016-03-02 | $7.70M derived: sum of 3 quarters · filed 2016-03-02 | $9.90M 10-K · filed 2016-03-02 |
| 2014-09-30 | $2.20M 10-Q · filed 2015-11-04 | $4.30M derived: sum of 2 quarters · filed 2015-11-04 | $6.50M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $2.10M 10-Q · filed 2015-08-05 | $4.40M 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | $9.30M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |